重复发表,WB胶图无法重复,论文从Brain Research撤稿

撤稿文章标题：

ASIC1a在槲皮素诱导局灶性脑缺血神经保护中的作用

作者单位：印度德里核医学和联合科学研究所回旋和放射药物科学部

本文已撤回：

请参阅别的人关于撤离的政策（http://www.elsevier.com/locate/withdrawalpolicy）。

本文正在根据作者的要求撤回。

作者提供以下原因：

1.本文的第一个作者省略了其中一名贡献者的名称，并没有透露他在另一个中心参与了类似的研究。这些研究的结果以前在另一个杂志中发表，导致本文中的图像与Mishra V等人的图像之间引起惊人的相似性，2010年神经医生https://doi.org/10.1016/j.neuropharm.2010.08 .08。015。

2.作者无法再现论文中给出的Western印迹数据的结果。

应该指出的是，主编对事实上，关于这些研究中的一些图像之前在另一个期刊中的无关研究中发表了一些事实。

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).

This article is being retracted at the request of the Authors.

The authors provided the following reasons:

1. The first author of the paper omitted the name of one of the contributors and did not disclose that he had been involved in similar studies at another Center. The results of these studies were previously published in another journal, resulting in a striking similarity between the images in this article and that of Mishra V et al., 2010 Neuropharmacology https://doi.org/10.1016/j.neuropharm.2010.08.015.

2. The authors were not able to reproduce the results of the Western blotting data given in the paper.

It should be noted that the Editor-in-Chief has serious concerns about the fact that some images in these studies were previously published in unrelated studies in another journal.

https://linkinghub.elsevier.com/retrieve/pii/S0006899321005886

来源：gongzhong号pubpeer

声明：转载此文是出于传递更多信息之目的。若有来源标注错误或侵犯了您的合法权益，请作者持权属证明与本网联系，我们将及时更正、删除，谢谢

Pubpeer，专注科研工作者。请长按上方ErWeiMa。投稿、合作、转载授权事宜请联系,本号，回复2021，提供专业群邀请ID：CnPubmed或邮箱：Pubpeer@qq.com